介绍巴塞尔排名前三的风投机构，涵盖深科技投资者Kickfund、生命科学导向的BioMedPartners以及诺华风投基金等信息。
Basel's reputation in healthcare and technology is backed by a strong group of investors. These firms are consistently placing bets on early-stage startups changing the industry.
You'll find established names like Novartis Venture Fund, with over 70 exits, alongside newer funds like Kickfund that have quickly made dozens of investments. It's a healthy mix of experience and fresh energy for founders seeking capital.
Below is our list of the best 3 VC firms in Basel.
Failory's Top 3 Picks
Tool
Fundraising OS
Everything you need to raise funding for your startup, including 3,500+ investors, 7 tools, 18 templates and 3 learning resources.
Kickfund invests in Swiss deep-tech startups at the pre-seed and seed stages, exclusively backing winners of the Venture Kick competition. The fund acts as a co-investor during early equity rounds to help grow the national innovation ecosystem and give Swiss startups global visibility.
Year Founded2022 Founders— Investment StageConvertible Note, Early Stage, SeedNº of Investments37 (7 as Lead Investor) Nº of Exits1 Contactinfo@kickfund.chAs one of Europe's leading venture capital firms, BioMedPartners directs private equity and mezzanine financing toward early and mid-stage healthcare and human life science companies. They concentrate on ventures in pharmaceuticals, biotechnology, diagnostics, and medical technology, guiding them from initial funding rounds to later stages of expansion.
Year Founded2003 FoundersGerhard Ries Investment StageEarly Stage, Late StageNº of Investments84 (27 as Lead Investor) Nº of Exits21 (8 IPO'd) Contactinfo@biomedvc.com / +41 61 270 3500As the venture arm of global healthcare company Novartis, they invest in early-stage life sciences and biotech companies developing novel therapeutics and platforms to address unmet medical needs. This strategic fund acts as a long-term partner, providing deep scientific expertise and substantial capital to build companies from the ground up, with a portfolio that includes biotech pioneers like Alnylam.
Year Founded1996 FoundersArgeris Karabelas Total Funding$720MIndustriesLife Sciences, BiotechInvestment StageEarly Stage, Late Stage, Post-Ipo, SeedNº of Investments267 (73 as Lead Investor) Nº of Exits75 (35 IPO'd) Top Portfolio StartupsEnterprise Therapeutics, Expansion Therapeutics, ImmunitasContactklydon@sosei.com / 877 280 2296The All-In-One Newsletter for Startup Founders
90% of startups fail. Learn how to not to with our weekly guides and stories. Join 40,000+ founders.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.